VULVOVAGINAL ULCERATION

VULVOVAGINAL ULCERATION was reported 49 times

VULVOVAGINAL ULCERATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
1 Iron Chelator [EPC] 1 0.0000
2 Provitamin D2 Compound [EPC] 1 0.0000
3 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
5 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
6 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
7 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
8 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
9 Glycopeptide Antibacterial [EPC] 1 0.0000
10 Calcium [EPC] 2 0.0000
11 Azole Antifungal [EPC] 2 0.0000
12 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
13 Retinoid [EPC] 3 0.0000
14 Estrogen [EPC] 2 0.0000
15 Progestin [EPC] 3 0.0000
16 Proton Pump Inhibitor [EPC] 6 0.0000
17 Purine Antimetabolite [EPC] 1 0.0000
18 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
19 Fluoroquinolone Antibacterial [EPC] 1 0.0000
20 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
21 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
22 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
30 Corticosteroid [EPC] 3 0.0000
31 Insulin Analog [EPC] 1 0.0000
32 Kinase Inhibitor [EPC] 1 0.0000